Wells Fargo’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Wells Fargo’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,000	Closed	-$47K	–	7655
2020 Q4	$47K	Buy	+20,000	New	+$986K	﹤0.01%	5606

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wells Fargo's GBT Position: Q4 2022 in Review

Wells Fargo sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 153,804 shares — an estimated $10.5M sold.

Wells Fargo first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $12.5M in Q4 2019. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Wells Fargo reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Wells Fargo sold 153,804 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $10.5M.
Wells Fargo first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
Wells Fargo's Global Blood Therapeutics, Inc. position peaked at $12.5M in Q4 2019.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Wells Fargo's 13F filing for Q4 2022, filed 13 Feb 2023.